Algernon Pharmaceuticals Inc. C.AGN

Were these recent Japanese studies ?? Excellent comments ...

[talisman47]

 

 

 

 

 

@Hasetohru

·

Sep 19

 

As I suppose, Ifenprodil is saving lives and a real silver bullet of Covid-19 treatment. On the contrary, our blood has a real life-threating Homocysteic acid which is a strong activator of NMDA receptor than glutamate. This HCA induces covid-19 aggravation.

Quote Tweet

 

 

 

Ronald M. Chavin

 

@rmchavin

· Sep 18

9-18-2020: Vancouver's Algernon Pharma wants to advance their NMDA receptor inhibitor, NP-120 (ifenprodil), to a global Phase 3 clinical trial for mid-stage and end-stage COVID-19: https://en.wikipedia.org/wiki/Ifenprodil https://algernonpharmaceuticals.com/ipf-np-120/ https://finance.yahoo.com/chart/AGNPF https://streetwisereports.com/article/2020/09/18/pharma-greenlighted-to-continue-multinational-covid-19-study.html…

 

 

 

2

 

3

 

 

 

 

 

 

@Hasetohru

·

Sep 18

 

Yes, Ifenprodil is saving lives of patients. What a wondeful it is ! We can overcome Covid-19 with Ifenprodil !!

Quote Tweet

 

 

 

R a n g j o i r

 

@Rangjoir

· Sep 17

Replying to @AlgernonPharma

And according to a doctor administrating the study, it’s working wonderfully. Every single patient on ifenprodil has either been moved off the ventilator or has not needed one. Ifenprodil is going to save lives!

 

 

 

2

 

2

 

 

 

 

 

 

@Hasetohru

·

Sep 16

 

Covid-19 aggravation, NMDA receptor in lung increases, which induces AD patients death strongly. Because AD patient's blood HCA increases its level and activates covid-19 increased NMDA receptor and induces death.

 

 

 

 

1

 

1

 

 

 

 

 

 

@Hasetohru

·

Sep 16

 

Ifenpridol is a real promising drug for COVID-19. Because COVID-19 increases NMDA receptor of immune cell in the lung, which induces cytokine storm and finally death. Blood HCA (homocysteic acid) can stimulate NMDA receptor. It's a real danger.

 

 

 

 

3

 

2

 

 

 

 

 

 

@Hasetohru

·

Sep 8

 

Yes, Ifenprodil is a promising drug for IPF and Chronic cough. But why does lung cell increases its NMDA receptor? Covid-19 virus disturbs our gene information which control NMDA receptor formation, I am afraid. Its mechanism is key point for treatment.

Quote Tweet

 

 

 

Algernon Pharmaceuticals

 

@AlgernonPharma

· Sep 8

The idiopathic pulmonary fibrosis (IPF) and chronic cough markets have both exceeded $1 billion. As a way to help address unmet patient needs, we continue to advance our lead drug #Ifenprodil in a Phase 2 trial: https://bit.ly/2ZiNl0I #AGNPhase2 $AGN.CN $AGW $AGNPF

 

 

 

 

 

 

 

 

 

0:45

305 views

 

 

 

1

 

1

 

2

 

 

 

 

 

 

@Hasetohru

·

Sep 5

 

COVID-19 induces AD patient's death more strongly. Why? Recent Ifenprodil (NMDA receptor inhibitor) effective treatment of COVID-19 ALI is very promising, which shows COVID-19 induces strong activation of NMDAr. That is a reason why. NMDA receptor, AD pathology.

 

 

 

 

1

 

2

 

 

 

 

 

 

@Hasetohru

·

Sep 3

 

Ifenprodil is a real silver bullet of covid-19 aggravation treatment. Covid-19 increases extraordinary NMDA receptor in lung and also increases glutamate level. Ifenprodil inhibits NMDA receptor signal which is stimulated by glutamate. But blood HCA also activates NMDA receptor.

 

 

 

 

1

 

1

 

 

 

 

 

 

@Hasetohru

·

Sep 3

 

Corvid-19 and Alzheimer's disease are very similar pathology. Corvid-19 increases NMDA receptor in lung, which activates NMDA receptor signal. AD stimulates NMDA receptor also. What mechanism exists between corvid-19 and AD? Blood HCA. It is a our answer.

 

 

 

 

1

 

1

 

 

 

 

 

 

@Hasetohru

·

Aug 27

 

Now acceptable thing is that our blood homocysteic acid which activates strongly NMDA receptor than glutamate does is really danger in COVID-19 infection. Then first our blood HCA should be decrease to prevent covid aggrevation. What do you think?

Quote Tweet

 

 

 

Algernon Pharmaceuticals

 

@AlgernonPharma

· Aug 26

Our CEO and Dr. Theodore Price discuss the science behind Ifenprodil as a potentially effective treatment to reduce the severity and duration of a #COVID19 infection. Learn more in the @utdmercury article we are featured in. $AGN.CN $AGW $AGNPF https://utdmercury.com/an-effective-treatment-to-reduce-the-severity-and-duration-of-a-covid-infection/…

 

 

 

1

 

3

 

 

 

 

 

 

@Hasetohru

·

Aug 23

 

Quote Tweet

 

 

 

@asahi_apital

· Aug 23

https://asahi.com/articles/ASN8Q666PN8QULFA008.html…

 

 

 

 

 

 

 

 

 

 

 

 

@Hasetohru

·

Aug 17

 

Summer heat induces our stress reaction, which induces in turn the oxidative stress and produces our blood HCA. This HCA can transmit the pain information through NMDA receptor. Pain and our stress reaction.

Quote Tweet

 

 

 

Mayo Clinic

@MayoClinic

· Aug 17

How and why does summer weather sometimes trigger these #headaches? https://bit.ly/313aqFI via @gulftoday

 

 

 

1

 

1

 

 

 

 

 

 

@Hasetohru

·

Aug 14

 

Yes, obesity increases our cholesterol, which stimulates NMDA receptor activity. That is a risk of AD.

Quote Tweet

 

 

 

Ian Kremer

 

@LEAD_Coalition

· Aug 14

How #obesity can increase #Alzheimers risk https://newatlas.com/health-wellbeing/imaging-obesity-bmi-dementia-alzheimers-brain-blood-flow/… via @intenseCA #dementia #health #fitness @EverydayHealth @ADevotedYogi @NeilFlochMD @LoriShemek @harrypetsanis @HeidiHmoretti @exerciseworks @DancinginLife @HillBeverlyhill @robynstevensPR @karenmcdougal98

 

 

 

 

 

1

 

1

 

 

 

 

 

 

New to Twitter?

Sign up now to get your own personalized timeline!

Sign up

dddddddddddD

 

 

@Hasetohru

·

Sep 19

 

As I suppose, Ifenprodil is saving lives and a real silver bullet of Covid-19 treatment. On the contrary, our blood has a real life-threating Homocysteic acid which is a strong activator of NMDA receptor than glutamate. This HCA induces covid-19 aggravation.

Quote Tweet

 

 

 

Ronald M. Chavin

 

@rmchavin

· Sep 18

9-18-2020: Vancouver's Algernon Pharma wants to advance their NMDA receptor inhibitor, NP-120 (ifenprodil), to a global Phase 3 clinical trial for mid-stage and end-stage COVID-19: https://en.wikipedia.org/wiki/Ifenprodil https://algernonpharmaceuticals.com/ipf-np-120/ https://finance.yahoo.com/chart/AGNPF https://streetwisereports.com/article/2020/09/18/pharma-greenlighted-to-continue-multinational-covid-19-study.html…

 

 

 

2

 

3

 

 

 

 

 

 

@Hasetohru

·

Sep 18

 

Yes, Ifenprodil is saving lives of patients. What a wondeful it is ! We can overcome Covid-19 with Ifenprodil !!

Quote Tweet

 

 

 

R a n g j o i r

 

@Rangjoir

· Sep 17

Replying to @AlgernonPharma

And according to a doctor administrating the study, it’s working wonderfully. Every single patient on ifenprodil has either been moved off the ventilator or has not needed one. Ifenprodil is going to save lives!

 

 

 

2

 

2

 

 

 

 

 

 

@Hasetohru

·

Sep 16

 

Covid-19 aggravation, NMDA receptor in lung increases, which induces AD patients death strongly. Because AD patient's blood HCA increases its level and activates covid-19 increased NMDA receptor and induces death.

 

 

 

 

1

 

1

 

 

 

 

 

 

@Hasetohru

·

Sep 16

 

Ifenpridol is a real promising drug for COVID-19. Because COVID-19 increases NMDA receptor of immune cell in the lung, which induces cytokine storm and finally death. Blood HCA (homocysteic acid) can stimulate NMDA receptor. It's a real danger.

 

 

 

 

3

 

2

 

 

 

 

 

 

@Hasetohru

·

Sep 8

 

Yes, Ifenprodil is a promising drug for IPF and Chronic cough. But why does lung cell increases its NMDA receptor? Covid-19 virus disturbs our gene information which control NMDA receptor formation, I am afraid. Its mechanism is key point for treatment.

Quote Tweet

 

 

 

Algernon Pharmaceuticals

 

@AlgernonPharma

· Sep 8

The idiopathic pulmonary fibrosis (IPF) and chronic cough markets have both exceeded $1 billion. As a way to help address unmet patient needs, we continue to advance our lead drug #Ifenprodil in a Phase 2 trial: https://bit.ly/2ZiNl0I #AGNPhase2 $AGN.CN $AGW $AGNPF

 

 

 

 

 

 

 

 

 

0:45

305 views

 

 

 

1

 

1

 

2

 

 

 

 

 

 

@Hasetohru

·

Sep 5

 

COVID-19 induces AD patient's death more strongly. Why? Recent Ifenprodil (NMDA receptor inhibitor) effective treatment of COVID-19 ALI is very promising, which shows COVID-19 induces strong activation of NMDAr. That is a reason why. NMDA receptor, AD pathology.

 

 

 

 

1

 

2

 

 

 

 

 

 

@Hasetohru

·

Sep 3

 

Ifenprodil is a real silver bullet of covid-19 aggravation treatment. Covid-19 increases extraordinary NMDA receptor in lung and also increases glutamate level. Ifenprodil inhibits NMDA receptor signal which is stimulated by glutamate. But blood HCA also activates NMDA receptor.

 

 

 

 

1

 

1

 

 

 

 

 

 

@Hasetohru

·

Sep 3

 

Corvid-19 and Alzheimer's disease are very similar pathology. Corvid-19 increases NMDA receptor in lung, which activates NMDA receptor signal. AD stimulates NMDA receptor also. What mechanism exists between corvid-19 and AD? Blood HCA. It is a our answer.

 

 

 

 

1

 

1

 

 

 

 

 

 

@Hasetohru

·

Aug 27

 

Now acceptable thing is that our blood homocysteic acid which activates strongly NMDA receptor than glutamate does is really danger in COVID-19 infection. Then first our blood HCA should be decrease to prevent covid aggrevation. What do you think?

Quote Tweet

 

 

 

Algernon Pharmaceuticals

 

@AlgernonPharma

· Aug 26

Our CEO and Dr. Theodore Price discuss the science behind Ifenprodil as a potentially effective treatment to reduce the severity and duration of a #COVID19 infection. Learn more in the @utdmercury article we are featured in. $AGN.CN $AGW $AGNPF https://utdmercury.com/an-effective-treatment-to-reduce-the-severity-and-duration-of-a-covid-infection/…

 

 

 

1

 

3

 

 

 

New to Twitter?

Sign up now to get your own personalized timeline!

Sign up